Goldman Sachs on Monday downgraded nutrition, health, and beauty company DSM-Firmenich (DSFIR.AS, DSFIR.SW) to sell from neutral and decreased the price target to 65.00 euros from 75.00 euros.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)